Dr. Cécilia Ménard-Moyon obtained her PhD in 2005 at Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA)/Saclay (France). After a 1-year postdoc at the University of York (UK) and 18 months in a company in Belgium (Nanocyl SA), she joined CNRS as Research Associate in 2008 in the Laboratory of Immunology, Immunopathology and Therapeutic Chemistry in Strasbourg (France). In 2021 she was promoted CNRS Research Director. Her research interests are focused on the functionalization of carbon-based nanomaterials and 2D materials for biomedical applications, the self-assembly of amino acid derivatives and peptides, as well as the formation of hydrogels for on-demand drug delivery. She has published ~100 articles and 10 book chapters (h-index: 42, > 4500 citations). She is the coordinator of the Horizon Europe Marie Skłodowska-Curie Actions Doctoral Networks Melomanes project.